02/29/2024
U.S. Population Classified as ‘Immunocompromised’ Explodes Higher.
New report nearly doubles the GeoVax addressable market of Immunocompromised Patients (i.e. potential customers) from 15 Million, to 23 Million patients! Not updated were the estimated 260 million people worldwide, who have weakened immune systems.
,
Biotech News2024 Watch ListAll NewsClientCoronaVirusInstitutional Analyst Newsletter U.S. Population Classified as ‘Immunocompromised’ Explodes Higher, in Latest JAMA Report. By Editor / Curator - February 29, 2024 Facebook Twitter Google+ Pinterest Linkedin Email New report nearly doubles the G...
